stockrow
Friday 6 November 2026
Export AWHL’s income statement to Excel — free account
Aspira Women's Health Inc.
AWHL Healthcare Diagnostics & Research
Aspira Women's Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.2 million, roughly unchanged from fiscal 2024.
- Revenue
- −14.9%
- EPS
- +28.6%
- Free cash flow
- −24.6%
- Total debt
- +25.9%
Quarter to June 2026, against a year earlier
0.16
0.03
−15.79%
Follow AWHL
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
3 | 4 | 4 | 4 | 3 | 5 | 4 | 3 | 3 | 5 |
Altman Z-Score |
(65.61) | (61.42) | (49.16) | (36.97) | 7.60 | (6.76) | (42.88) | (121.70) | (143.14) | (141.56) |
P/S ratio |
21.74 | 32.86 | 6.89 | 15.46 | 145.39 | 28.90 | 4.61 | 4.22 | 1.09 | 2.33 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(165.44) | (177.47) | (116.70) | (100.67) | (74.09) | (34.73) | (101.39) | (290.18) | (337.28) | (334.76) |
Beneish M-Score |
— | (4.82) | — | (2.17) | (1.92) | (2.97) | (1.59) | (2.45) | (3.38) | (7.05) |
P/Operating CF |
(20.78) | (47.65) | (9.15) | (24.44) | (142.18) | (25.73) | (5.34) | (11.19) | (9.83) | (10.85) |
P/B ratio |
15.27 | 30.10 | 2.94 | 8.03 | 69.57 | 6.52 | 5.41 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
15.27 | 30.10 | 2.94 | 8.03 | 69.57 | 6.52 | 5.41 | 0.00 | 0.00 | 0.00 |
EV/Sales |
20.46 | 31.62 | 4.31 | 13.24 | 142.83 | 23.98 | 3.41 | 4.18 | 1.13 | 2.33 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(3.87) | (12.14) | (1.40) | (4.63) | (45.09) | (5.96) | (0.90) | (2.41) | (0.86) | (3.06) |
EV/FCF |
(3.55) | (12.05) | (1.39) | (4.59) | (43.63) | (5.92) | (0.89) | (2.40) | (0.85) | (3.05) |
Quick Ratio |
2.15 | 2.20 | 3.42 | 3.17 | 2.92 | 4.87 | 2.63 | 0.79 | 0.50 | 0.85 |
Current Ratio |
2.39 | 2.42 | 3.64 | 3.37 | 3.10 | 5.10 | 2.95 | 1.03 | 0.77 | 1.17 |
Net Debt/EBITDA |
0.24 | 0.40 | 0.74 | 0.68 | 0.67 | 1.04 | 0.32 | 0.02 | (0.02) | 0.00 |
Debt/Assets |
23.06% | 22.22% | 12.98% | 11.53% | 24.14% | 9.00% | 20.04% | 36.19% | 38.63% | 32.44% |
Debt/Equity |
0.49 | 0.49 | 0.21 | 0.18 | 0.49 | 0.12 | 0.50 | (0.96) | (0.83) | (0.26) |
Asset Turnover |
0.18 | 0.40 | 0.32 | 0.36 | 0.28 | 0.22 | 0.28 | 0.77 | 1.56 | 1.68 |
Operating CF/Net income |
0.93 | 0.71 | 0.82 | 0.85 | 0.82 | 0.87 | 1.04 | 0.95 | 0.93 | 0.55 |
Capex/Depreciation |
(1.74) | (0.08) | (0.17) | (0.40) | (1.85) | (0.61) | (0.88) | (0.12) | (0.40) | (3.58) |
Interest Coverage |
— | (248.60) | (515.14) | (258.95) | (1,798.10) | — | (1,831.65) | — | (493.27) | (193.00) |
| (140.49%) | (319.12%) | (215.38%) | (191.78%) | (194.02%) | (158.74%) | (160.88%) | (723.45%) | 531.42% | 269.20% | |
| (103.30%) | (147.45%) | (120.30%) | (120.76%) | (107.11%) | (104.35%) | (102.25%) | (141.23%) | (222.82%) | (233.49%) | |
ROIC |
(2,532.86%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(274.24%) | (234.55%) | (134.86%) | (155.72%) | (135.79%) | (97.04%) | (268.03%) | (5,119.63%) | 1,076.81% | (1,981.40%) |
Average Days of Receivables |
37.99 | 23.97 | 93.97 | 74.32 | 67.88 | 55.03 | 55.53 | 58.18 | 39.35 | 47.80 |
Research and Development Expense of Revenue |
82.21% | 26.82% | 18.02% | 22.43% | 45.24% | 78.01% | 72.30% | 44.08% | 35.57% | 31.23% |
Selling, General and Administrative Expense of Revenue |
481.68% | 314.35% | 350.28% | 340.57% | 367.94% | 445.43% | 361.00% | 219.35% | 201.38% | 118.82% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 |
Share Based Compensation of Revenue |
44.63% | 46.11% | 36.06% | 26.29% | 33.28% | 51.95% | 29.50% | 18.83% | 16.27% | 5.76% |
Graham Net Nets |
0.03 | 0.02 | 0.31 | 0.12 | 0.01 | 0.15 | 0.16 | (0.09) | (0.39) | (0.39) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.27 | 2.00 | 1.30 |
Earnings Yield |
(25.44%) | (11.11%) | (56.64%) | (22.21%) | (2.67%) | (15.81%) | (79.12%) | (44.29%) | (138.03%) | (58.65%) |
Free Cash Flow Yield |
(26.50%) | (7.99%) | (45.07%) | (18.66%) | (2.25%) | (14.01%) | (82.90%) | (41.24%) | (121.07%) | (32.80%) |
Revenue per Share |
0.76 | 0.82 | 0.65 | 0.79 | 0.69 | 0.92 | 1.05 | 0.99 | 0.65 | 0.27 |
Operating CF per Share |
(4.01) | (2.14) | (2.00) | (2.24) | (2.19) | (3.69) | (4.00) | (1.72) | (0.86) | (0.21) |
Capex per Share |
(0.36) | (0.02) | (0.02) | (0.02) | (0.07) | (0.02) | (0.03) | 0.00 | 0.00 | (0.01) |
Free Cash Flow per Share |
(4.37) | (2.16) | (2.03) | (2.27) | (2.27) | (3.72) | (4.03) | (1.72) | (0.86) | (0.22) |
Cash per Share |
1.51 | 1.46 | 2.00 | 2.03 | 2.48 | 5.01 | 1.71 | 0.28 | 0.13 | 0.05 |
Shareholders Equity per Share |
1.08 | 0.90 | 1.53 | 1.51 | 1.45 | 4.07 | 0.90 | (0.26) | (0.18) | (0.20) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.08 | 0.90 | 1.53 | 1.51 | 1.45 | 4.07 | 0.90 | (0.26) | (0.18) | (0.20) |
Free Cash Flow |
(15.22) | (8.19) | (9.48) | (13.10) | (15.22) | (27.58) | (31.30) | (15.92) | (12.15) | (7.43) |
Working Capital |
3.55 | 3.70 | 7.82 | 9.43 | 12.60 | 32.17 | 10.78 | 0.16 | (1.28) | 0.60 |
Capital Expenditures |
(1.26) | (0.06) | (0.11) | (0.13) | (0.49) | (0.18) | (0.23) | (0.02) | (0.04) | (0.40) |
Net Current Asset Value |
1.85 | 2.22 | 6.53 | 8.32 | 8.72 | 29.10 | 5.92 | (3.35) | (3.87) | (8.32) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.48 | 0.02 | 0.04 | 0.03 | 0.11 | 0.03 | 0.03 | 0.00 | 0.00 | 0.04 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.38 | 0.67 | 1.11 | 0.94 | 0.45 | 0.65 | 0.72 | 1.21 | 1.33 | 2.38 |
Cash ROIC |
(140.27%) | (77.17%) | (52.69%) | (59.44%) | (48.98%) | (38.82%) | (131.70%) | (637.23%) | (915.60%) | 218.08% |
Accounts Receivable Turnover |
14.60 | 13.00 | 6.16 | 5.31 | 5.20 | 7.20 | 7.20 | 6.77 | 7.50 | 8.39 |
Accounts Payable Turnover |
2.89 | 3.58 | 3.71 | 3.70 | 3.49 | 2.88 | 3.24 | 3.63 | 2.16 | 1.94 |
Inventory Turnover |
29.98 | 29.89 | 32.39 | 57.15 | 124.18 | 36.76 | 15.76 | 14.34 | 13.39 | 11.34 |
Average Days of Payables |
119.19 | 93.32 | 110.36 | 93.35 | 117.89 | 146.10 | 83.29 | 118.26 | 214.19 | 136.78 |
Days of Inventory on Hand |
12.58 | 12.78 | 10.69 | 2.73 | 3.21 | 16.94 | 29.87 | 21.29 | 32.13 | 28.31 |
Average Receivables |
0.18 | 0.24 | 0.50 | 0.86 | 0.89 | 0.95 | 1.14 | 1.35 | 1.22 | 1.10 |
Average Payables |
0.93 | 0.81 | 0.85 | 0.90 | 0.98 | 1.30 | 1.19 | 1.07 | 1.72 | 1.71 |
Average Inventory |
0.09 | 0.10 | 0.10 | 0.06 | 0.03 | 0.10 | 0.25 | 0.27 | 0.28 | 0.29 |
Average Assets |
14.49 | 7.76 | 9.45 | 12.62 | 16.72 | 30.34 | 29.23 | 11.82 | 5.88 | 5.47 |
Average Common Equity |
10.65 | 3.58 | 5.28 | 7.95 | 9.23 | 19.95 | 18.58 | 2.31 | (2.46) | (4.75) |
Columns are period end dates · fundamentals updated 25 Oct 2026